Investors & Media

SEC Filing Details

Investor Relations Menu
Financials & Filings
Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Emily White
Solebury Strategic Communications
ewhite@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

Document Details

Form
Filing Date
May 10, 2023
Document Date
May 8, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.
Filer
HAUSMAN DIANA